VISANSTA
LIVE

Serial Number

79295637

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

VISANSTA Trademark

Serial Number: 79295637 • Registration: 6311512

VISANSTA is a trademark filed by NOVARTIS AG on September 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 4, 2020

Registration Date

April 6, 2021

Published for Opposition

January 19, 2021

Cancellation Date

December 12, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 25, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Dec 25, 2025 DETH
NOTIFICATION PROCESSED BY IB
Jun 13, 2021 GPNX
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 6, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 6, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jan 23, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2020 CNSA
ASSIGNED TO EXAMINER
Dec 10, 2020 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 2, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2020 COAR
APPLICATION FILING RECEIPT MAILED
Oct 24, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 17, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 8, 2020 SDRC